Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non–small Cell Lung Cancer | Citedby Results | Cancer Research Communications | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Circulating Tumor DNA Monitoring Reveals Molecular Progression before Radiologic Progression in a Real-life Cohort of Patients with Advanced Non–small Cell Lung Cancer

Cancer Research Communications (2022) 2 (10): 1174–1187.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

The evolving value assessment of cancer therapies: Results from a modified Delphi study

Myrto Lee
Hugo Larose
Martin Gräbeldinger
Jon Williams
Anne-Marie Baird
Susan Brown
Johannes Bruns
Russell Clark
Javier Cortes
Giuseppe Curigliano
Andrea Ferris
Louis P. Garrison
Y.K. Gupta
Ravindran Kanesvaran
Gary Lyman
Luca Pani
Zack Pemberton-Whiteley
Tomas Salmonson
Peter Sawicki
Barry Stein
Dong-Churl Suh
Galina Velikova
Jens Grueger

Health Policy OPEN (2024) 6: 100116.

Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients

Tatiana M. Zavarykina
Polina K. Lomskova
Irina V. Pronina
Svetlana V. Khokhlova
Marina B. Stenina
Gennady T. Sukhikh

International Journal of Molecular Sciences (2023) 24 (23): 17073.

Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers

Yongjun Cha
Sheehyun Kim
Sae-Won Han

Cancer Research and Treatment (2023) 55 (2): 367.